Cargando…
Development and performance of a hereditary hemorrhagic telangiectasia-specific quality-of-life instrument
Hereditary hemorrhagic telangiectasia (HHT) is characterized by arteriovenous malformations and telangiectasia, with primary clinical manifestations of epistaxis and gastrointestinal bleeding and resultant anemia. HHT negatively affects health-related quality of life (HR-QoL); however, existing tool...
Autores principales: | Kasthuri, Raj S., Chaturvedi, Shruti, Thomas, Sonia, Vandergrift, Nathan, Bann, Carla, Schaefer, Nicole, Clancy, Marianne S., Pyeritz, Reed, McCrae, Keith R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327531/ https://www.ncbi.nlm.nih.gov/pubmed/35877137 http://dx.doi.org/10.1182/bloodadvances.2022007748 |
Ejemplares similares
-
Pazopanib for severe bleeding and transfusion-dependent anemia in hereditary hemorrhagic telangiectasia
por: Parambil, Joseph G., et al.
Publicado: (2021) -
Biomarker signatures in cancer patients with and without venous thromboembolism events: a substudy of CASSINI
por: Khorana, Alok A., et al.
Publicado: (2022) -
Pazopanib may reduce bleeding in hereditary hemorrhagic telangiectasia
por: Faughnan, Marie E., et al.
Publicado: (2018) -
Hereditary Hemorrhagic Telangiectasia
por: Kamath, Nagesh, et al.
Publicado: (2015) -
Imaging of Hereditary Hemorrhagic Telangiectasia
por: Carette, Marie-France, et al.
Publicado: (2008)